Healthcare app Healthify raises $20 million, plans for US expansion

Health and wellness AI platform Healthify, also known as HealthifyMe, announced the closure of a $45 million equity round in late October, successfully raising $20 million in fresh capital. The investment was led by existing investors Khosla Ventures and Leapfrog Investments, with additional support from Claypond Capital, Indian healthcare billionaire Ranjan Pai’s family investment office. 

With the tagline “health made easy with AI,” Healthify is an app that offers a personalized AI coach for meal tracking, nutritional advice, diet and workout suggestions to help users work towards their health and wellness goals. 

Founded in 2012, Healthify has had a successful run in India for more than a decade and now finds itself getting ready for a U.S. expansion. Bangalore-based Healthify has offices in Malaysia and Singapore in addition to its headquarters in India. 

Using a combination of AI software, wearable devices, and fitness trainers, Healthify claims to have served over 40 million users across 300 cities in India.

The fresh capital will fuel Healthify’s expansion into the U.S. market and enhance its AI-driven nutrition and fitness coaching capabilities, the company said in a press release.

READ: Asha Health: Transforming medical practices with AI to fill care gaps and drive revenue (November 15, 2024)

University of Pennsylvania alum Tushar Vashist co-founded Healthify with fellow ivy leaguer, MIT graduate Mathew Cherian, who helped develop the Android and iOS applications and later exited the healthcare startup in 2021. 

“We’re launching our AI-first #beta app in the U.S. next month, and I couldn’t be more excited,” Vashist shared in a LinkedIn post, with plans for the latest iteration of the app launching in India before the new year. 

According to CNBC, the healthcare startup is finetuning its application to cater to the needs of diverse markets including the U.S., focusing on understanding common food items, fitness habits, and local dialects to ensure culturally-relevant health guidance for its users. 

Healthify’s Indian vertical has achieved operational profitability and expects to be EBITDA-positive (Earnings Before Interest, Taxes, Depreciation, and Amortization) by the end of the fiscal year. 

READ: AI to ease healthcare burden: Northeastern students develop ‘Eden’(November 11, 2024)

In addition to customer-centric business, Healthify is also focused on B2B operations such as corporate wellness partnerships and is pursuing collaborations with diagnostics, insurance, and pharmaceutical firms to drive sustainable health outcomes at scale.